Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic

Detalles Bibliográficos
Autores principales: Tatar, Erhan, Erdi, Zuleyha Can, Ozgur, Oyku, Tasdemir, Anıl, Tatar, Bengu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Nephrology - Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128974/
https://www.ncbi.nlm.nih.gov/pubmed/34003430
http://dx.doi.org/10.1007/s11255-021-02890-y
_version_ 1783694210424111104
author Tatar, Erhan
Erdi, Zuleyha Can
Ozgur, Oyku
Tasdemir, Anıl
Tatar, Bengu
author_facet Tatar, Erhan
Erdi, Zuleyha Can
Ozgur, Oyku
Tasdemir, Anıl
Tatar, Bengu
author_sort Tatar, Erhan
collection PubMed
description
format Online
Article
Text
id pubmed-8128974
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-81289742021-05-18 Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic Tatar, Erhan Erdi, Zuleyha Can Ozgur, Oyku Tasdemir, Anıl Tatar, Bengu Int Urol Nephrol Nephrology - Letter to the Editor Springer Netherlands 2021-05-18 2022 /pmc/articles/PMC8128974/ /pubmed/34003430 http://dx.doi.org/10.1007/s11255-021-02890-y Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Nephrology - Letter to the Editor
Tatar, Erhan
Erdi, Zuleyha Can
Ozgur, Oyku
Tasdemir, Anıl
Tatar, Bengu
Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
title Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
title_full Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
title_fullStr Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
title_full_unstemmed Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
title_short Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
title_sort importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the sars-cov-2 pandemic
topic Nephrology - Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128974/
https://www.ncbi.nlm.nih.gov/pubmed/34003430
http://dx.doi.org/10.1007/s11255-021-02890-y
work_keys_str_mv AT tatarerhan importanceofeculizumabtreatmentinrecurrenceofatypicalhemolyticuremicsyndromeduringthesarscov2pandemic
AT erdizuleyhacan importanceofeculizumabtreatmentinrecurrenceofatypicalhemolyticuremicsyndromeduringthesarscov2pandemic
AT ozguroyku importanceofeculizumabtreatmentinrecurrenceofatypicalhemolyticuremicsyndromeduringthesarscov2pandemic
AT tasdemiranıl importanceofeculizumabtreatmentinrecurrenceofatypicalhemolyticuremicsyndromeduringthesarscov2pandemic
AT tatarbengu importanceofeculizumabtreatmentinrecurrenceofatypicalhemolyticuremicsyndromeduringthesarscov2pandemic

Ejemplares similares